The extent of tumor invasiveness and metastasis, after anti-angiogenic therapies depends on the coordinated interaction of numerous proteins and enzymes controlled by several transcription factors such as HIF-1α and AP-132–34. This evidence concerns the gene HIF1A and neoplasm.